Category: Divisions
Vaccine appears to ‘mop up’ leukemia cells drug leaves behind
January 11, 2010
Johns Hopkins Kimmel Cancer Center researchers say preliminary studies show that a vaccine made with leukemia cells may be able to reduce or eliminate the last remaining cancer cells in some chronic myeloid leukemia, or CML, patients taking the drug Imatinib mesylate (Gleevec).
Seven from JHU named AAAS fellows
January 4, 2010
Seven Johns Hopkins researchers from four of the university’s schools have been elected by their peers as fellows of the American Association for the Advancement of Science.
BME holds first Undergraduate Research Day
January 4, 2010
The first Biomedical Engineering Undergraduate Research Day was conducted last semester on the Homewood campus to showcase and judge student research projects. Sixteen biomedical engineering undergraduates submitted abstracts and posters focusing on research they had conducted during the past year.
Unlocking the key to premature aging in children
January 4, 2010
Susan Michaelis conducts her research in a traditional laboratory, with beakers and flasks and microscopes strong enough to allow her to view and manipulate the infinitesimally small nuclei of cells.
Nanoparticles bypass mucus barrier, may deliver drugs
January 4, 2010
Johns Hopkins University researchers have created biodegradable nanosized particles that can easily slip through the body’s sticky and viscous mucus secretions to deliver a sustained-release medication cargo. The researchers say that these nanoparticles, which degrade over time into harmless components, could one day carry life-saving drugs to patients suffering from dozens of health conditions, including diseases of the eye, lung, gut or female reproductive tract.
1,000-plus admitted in U.S. annually for aviation-related injuries
January 4, 2010
The first-ever published study of aviation-related injuries and deaths in the United States finds that an average of 1,013 patients are admitted to U.S. hospitals with aviation-related injuries annually, and that an average of 753 aviation deaths occur each year.
Central Europe is focus of new initiative created at SAIS
December 14, 2009
Johns Hopkins’ Paul H. Nitze School of Advanced International Studies and the Austrian Marshall Plan Foundation of Vienna, Austria, last week announced a new initiative to support research and related activities focused on Central Europe. Daniel Hamilton, SAIS professor and founding director of the SAIS Center for Transatlantic Relations, will be appointed the first Austrian Marshall Plan Foundation Professor to head the initiative.
Bloomberg School establishes International Vaccine Access Center
December 14, 2009
The Johns Hopkins Bloomberg School of Public Health has established the International Vaccine Access Center to increase availability of lifesaving vaccines by overcoming many of the obstacles that often delay their usage and distribution. IVAC will also serve as a source of vaccine policy information and analysis and will develop and use evidence to advocate for improved global health policies and their implementation. Projects undertaken by IVAC are supported by grants from the GAVI Alliance and the Bill & Melinda Gates Foundation.
‘Mini’-transplant may reverse severe sickle cell
December 14, 2009
Results of a preliminary study by scientists at the National Institutes of Health and Johns Hopkins show that “mini” stem cell transplantation may safely reverse severe sickle cell disease in adults.
Scientists find potential new ‘twist’ in breast cancer detection
December 14, 2009
Working with mice, scientists at Johns Hopkins have shown that a protein made by a gene called “Twist” may be the proverbial red flag that can accurately distinguish stem cells that drive aggressive, metastatic breast cancer from other breast cancer cells.